EW - Stock Analysis & Overview

About Edwards Lifesciences Corporation

Medical - Devices

Healthcare

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy...

Edwards Lifesciences Corporation Key Metrics

Market Cap: $42B
52 Weeks Low: $58.93
52 Weeks High: $96.12
P/B: 5.62x
P/E: 28.35x
P/S: 6.96x

Upcoming Events

EW Analyst Forecasts

‌

EW Financials

EW Income Statement Key Metrics

Revenue(TTM)6.00 B
Gross Profit(TTM)4.61 B
EBITDA(TTM)1.72 B
Net Income(TTM)1.47 B
EPS Diluted(TTM)2.4299999999999997

Decode EW's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

EW earnings and revenue history

Gross Profit Margin vs Peers

Profit margin ratio of EW (0.770) is higher than the average of its peers (0.625).

Net Profit Margin vs Peers

Net profit margin ratio of EW (0.234) is higher than the average of its peers (0.083).

EW Return on Equity

See how efficiently EW generates profit for it's shareholders.

21.09%

100

Poor

Average

Strong

Return on Equity vs Peers

Return on Equity ratio of EW (0.211) is higher than the average of its peers (0.057).

Return on Equity Growth

EW's Return on Equity has shown poor growth over the past 10 years, increasing by only -5.47%.

EW Revenue Growth

See how EW has grown it's revenue over the past 10 years.

‌

Revenue Growth

EW's revenue has grown modestly over the past 10 years, increasing by over 9.96%.

Edwards Lifesciences Corporation

Page title

Section title